FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128317422> ?p ?o ?g. }

• W2128317422 endingPage "632" @default.
• W2128317422 startingPage "618" @default.
• W2128317422 abstract "Abstract Ansamycin antibiotics that target heat shock protein 90 function are being developed as anticancer agents but are also known to be dose limiting in patients due to hepatotoxicity. Herein, to better understand how the normal tissue toxicity of geldanamycins could be ameliorated to improve the therapeutic index of these agents, we examined the interactions of 17-allylamino-17-demethoxygeldanamycin (17AAG) and the secondary bile acid deoxycholic acid (DCA) in hepatocytes and fibroblasts. DCA and 17AAG interacted in a greater than additive fashion to cause hepatocyte cell death within 2 to 6 h of coadministration. As single agents DCA, but not 17AAG, enhanced the activity of extracellular signal-regulated kinase 1/2, AKT, c-Jun NH2-terminal kinase 1/2 (JNK1/2), and p38 mitogen-activated protein kinase (MAPK). Combined exposure of cells to DCA and 17AAG further enhanced JNK1/2 and p38 MAPK activity. Inhibition of JNK1/2 or p38 MAPK, but not activator protein-1, suppressed the lethality of 17AAG and of 17AAG and DCA. Constitutive activation of AKT, but not MAPK/extracellular signal-regulated kinase kinase 1/2, suppressed 17AAG- and DCA-induced cell killing and reduced activation of JNK1/2. DCA and 17AAG exposure promoted association of BAX with mitochondria, and functional inhibition of BAX or caspase-9, but not of BID and caspase-8, suppressed 17AAG and DCA lethality. DCA and 17AAG interacted in a greater than additive fashion to promote and prolong the generation of reactive oxygen species (ROS). ROS-quenching agents, inhibition of mitochondrial function, expression of dominant-negative thioredoxin reductase, or expression of dominant-negative apoptosis signaling kinase 1 suppressed JNK1/2 and p38 MAPK activation and reduced cell killing after 17AAG and DCA exposure. The potentiation of DCA-induced ROS production by 17AAG was abolished by Ca2+ chelation and ROS generation, and cell killing following 17AAG and DCA treatment was abolished in cells lacking expression of PKR-like endoplasmic reticulum kinase. Thus, DCA and 17AAG interact to stimulate Ca2+-dependent and PKR-like endoplasmic reticulum kinase–dependent ROS production; high levels of ROS promote intense activation of the p38 MAPK and JNK1/2 pathways that signal to activate the intrinsic apoptosis pathway. [Mol Cancer Ther 2007;6(2):618–32]" @default.
• W2128317422 created "2016-06-24" @default.
• W2128317422 creator A5001282484 @default.
• W2128317422 creator A5003769038 @default.
• W2128317422 creator A5011709526 @default.
• W2128317422 creator A5012592897 @default.
• W2128317422 creator A5047862807 @default.
• W2128317422 creator A5056911226 @default.
• W2128317422 creator A5061036144 @default.
• W2128317422 creator A5069980003 @default.
• W2128317422 creator A5073310914 @default.
• W2128317422 creator A5085316261 @default.
• W2128317422 creator A5086214666 @default.
• W2128317422 date "2007-02-01" @default.
• W2128317422 modified "2023-09-27" @default.
• W2128317422 title "17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines" @default.
• W2128317422 cites W1830803900 @default.
• W2128317422 cites W1976146332 @default.
• W2128317422 cites W1980938616 @default.
• W2128317422 cites W1991196199 @default.
• W2128317422 cites W1999965011 @default.
• W2128317422 cites W2000951995 @default.
• W2128317422 cites W2038810883 @default.
• W2128317422 cites W2048328091 @default.
• W2128317422 cites W2052464531 @default.
• W2128317422 cites W2059675893 @default.
• W2128317422 cites W2065551750 @default.
• W2128317422 cites W2066796380 @default.
• W2128317422 cites W2067487872 @default.
• W2128317422 cites W2068650460 @default.
• W2128317422 cites W2076496192 @default.
• W2128317422 cites W2077322645 @default.
• W2128317422 cites W2088788142 @default.
• W2128317422 cites W2098143955 @default.
• W2128317422 cites W2101055270 @default.
• W2128317422 cites W2110414129 @default.
• W2128317422 cites W2112417555 @default.
• W2128317422 cites W2120383034 @default.
• W2128317422 cites W2129718955 @default.
• W2128317422 cites W2132379232 @default.
• W2128317422 cites W2132702191 @default.
• W2128317422 cites W2133222720 @default.
• W2128317422 cites W2133789046 @default.
• W2128317422 cites W2139306838 @default.
• W2128317422 cites W2144818233 @default.
• W2128317422 cites W2145854692 @default.
• W2128317422 cites W2158341833 @default.
• W2128317422 cites W2163541635 @default.
• W2128317422 cites W2166356088 @default.
• W2128317422 cites W2172296418 @default.
• W2128317422 doi "https://doi.org/10.1158/1535-7163.mct-06-0532" @default.
• W2128317422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17308059" @default.
• W2128317422 hasPublicationYear "2007" @default.
• W2128317422 type Work @default.
• W2128317422 sameAs 2128317422 @default.
• W2128317422 citedByCount "32" @default.
• W2128317422 countsByYear W21283174222013 @default.
• W2128317422 countsByYear W21283174222014 @default.
• W2128317422 countsByYear W21283174222015 @default.
• W2128317422 countsByYear W21283174222016 @default.
• W2128317422 countsByYear W21283174222020 @default.
• W2128317422 countsByYear W21283174222021 @default.
• W2128317422 countsByYear W21283174222022 @default.
• W2128317422 countsByYear W21283174222023 @default.
• W2128317422 crossrefType "journal-article" @default.
• W2128317422 hasAuthorship W2128317422A5001282484 @default.
• W2128317422 hasAuthorship W2128317422A5003769038 @default.
• W2128317422 hasAuthorship W2128317422A5011709526 @default.
• W2128317422 hasAuthorship W2128317422A5012592897 @default.
• W2128317422 hasAuthorship W2128317422A5047862807 @default.
• W2128317422 hasAuthorship W2128317422A5056911226 @default.
• W2128317422 hasAuthorship W2128317422A5061036144 @default.
• W2128317422 hasAuthorship W2128317422A5069980003 @default.
• W2128317422 hasAuthorship W2128317422A5073310914 @default.
• W2128317422 hasAuthorship W2128317422A5085316261 @default.
• W2128317422 hasAuthorship W2128317422A5086214666 @default.
• W2128317422 hasBestOaLocation W21283174221 @default.
• W2128317422 hasConcept C104317684 @default.
• W2128317422 hasConcept C153911025 @default.
• W2128317422 hasConcept C184235292 @default.
• W2128317422 hasConcept C185592680 @default.
• W2128317422 hasConcept C190283241 @default.
• W2128317422 hasConcept C205260736 @default.
• W2128317422 hasConcept C2775932338 @default.
• W2128317422 hasConcept C2779399885 @default.
• W2128317422 hasConcept C2780297055 @default.
• W2128317422 hasConcept C2780749602 @default.
• W2128317422 hasConcept C51551487 @default.
• W2128317422 hasConcept C55493867 @default.
• W2128317422 hasConcept C57074206 @default.
• W2128317422 hasConcept C75217442 @default.
• W2128317422 hasConcept C86803240 @default.
• W2128317422 hasConcept C97029542 @default.
• W2128317422 hasConceptScore W2128317422C104317684 @default.
• W2128317422 hasConceptScore W2128317422C153911025 @default.
• W2128317422 hasConceptScore W2128317422C184235292 @default.
• W2128317422 hasConceptScore W2128317422C185592680 @default.
• W2128317422 hasConceptScore W2128317422C190283241 @default.

• next